AL Capital Holdings 2016 Ltd Stock TEL AVIV STOCK EXCHANGE
Equities
CPHO-M
IL0010843675
Pharmaceuticals
Sales 2022 | 49.3 18.7K | Sales 2023 | 44.23 16.78K | Capitalization | 25.49M 9.67B |
---|---|---|---|---|---|
Net income 2022 | -48M -18.21B | Net income 2023 | -88M -33.38B | EV / Sales 2022 | 1,234,605 x |
Net Debt 2022 | 17.5M 6.64B | Net Debt 2023 | 13.42M 5.09B | EV / Sales 2023 | 879,698 x |
P/E ratio 2022 |
-0.97
x | P/E ratio 2023 |
-0.22
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 65.07% |
Managers | Title | Age | Since |
---|---|---|---|
Ifat Kariv
CEO | Chief Executive Officer | 50 | - |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Revital Aviram
BRD | Director/Board Member | 66 | 15-02-14 |
Erez Navon
BRD | Director/Board Member | 50 | - |
Ifat Kariv
CEO | Chief Executive Officer | 50 | - |
1st Jan change | Capi. | |
---|---|---|
+26.32% | 3.83B | |
+129.49% | 2.24B | |
+68.25% | 61.17M | |
+265.38% | 56.9M |